STOCK TITAN

Planned 200,000-share NAMS (NASDAQ: NAMS) Rule 144 stock sale

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

NAMS reported that an affiliated holder has filed a Rule 144 notice to sell 200,000 ordinary shares through J.P. Morgan Securities LLC on or about 01/20/2026 on Nasdaq. The planned sale has an indicated aggregate market value of $6,330,000. The seller acquired the 200,000 shares from the issuer on the same date via a stock option exercise paid in cash. The filing also lists 113,390,804 ordinary shares outstanding for the issuer, providing context for the size of this planned transaction.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the NAMS Form 144 filing disclose?

The Form 144 discloses that an affiliated holder of NAMS intends to sell 200,000 ordinary shares under Rule 144, using J.P. Morgan Securities LLC as broker and listing Nasdaq as the exchange.

How many NAMS shares are planned to be sold and what is the market value?

The notice covers the planned sale of 200,000 ordinary shares of NAMS, with an indicated aggregate market value of $6,330,000 for this block.

How were the NAMS shares in this Form 144 acquired?

The 200,000 ordinary shares were acquired from the issuer via a stock option exercise on 01/20/2026, and the exercise was paid for in cash.

When is the NAMS Rule 144 sale expected to take place?

The filing lists an approximate date of sale of 01/20/2026 for the planned disposition of the 200,000 ordinary shares on Nasdaq.

How many NAMS shares are outstanding according to this filing?

The Form 144 indicates that there are 113,390,804 ordinary shares outstanding for NAMS, which provides a baseline for assessing the size of the planned sale.

Which broker is handling the NAMS Form 144 share sale?

The filing identifies J.P. Morgan Securities LLC, located at 390 Madison Avenue, New York, NY, as the broker for the planned sale of the 200,000 ordinary shares.

NewAmsterdam Pharma Company N.V

NASDAQ:NAMS

NAMS Rankings

NAMS Latest News

NAMS Latest SEC Filings

NAMS Stock Data

3.67B
96.15M
0.39%
107.02%
6.66%
Biotechnology
Pharmaceutical Preparations
Link
Netherlands
NARRDEN